GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake

Overview

Journal Endocrinology

Publisher Oxford University Press

Specialty Endocrinology

Date 2011 Dec 1

PMID 22128031

Citations 234

Authors

Amber L Alhadeff

Laura E Rupprecht

Matthew R Hayes

Affiliations

Soon will be listed here.

Abstract

Central glucagon-like-peptide-1 (GLP-1) receptor activation reduces food intake; however, brain nuclei and mechanism(s) mediating this effect remain poorly understood. Although central nervous system GLP-1 is produced almost exclusively in the nucleus of the solitary tract in the hindbrain, GLP-1 receptors (GLP-1R) are expressed throughout the brain, including nuclei in the mesolimbic reward system (MRS), e.g. the ventral tegmental area (VTA) and the nucleus accumbens (NAc). Here, we examine the MRS as a potential site of action for GLP-1-mediated control of food intake and body weight. Double immunohistochemistry for Fluorogold (monosynaptic retrograde tracer) and GLP-1 neuron immunoreactivity indicated that GLP-1-producing nucleus tractus solitarius neurons project directly to the VTA, the NAc core, and the NAc shell. Pharmacological data showed that GLP-1R activation in the VTA, NAc core, and NAc shell decreased food intake, especially of highly-palatable foods, and body weight. Moreover, blockade of endogenous GLP-1R signaling in the VTA and NAc core resulted in a significant increase in food intake, establishing a physiological relevance for GLP-1 signaling in the MRS. Current data highlight these nuclei within the MRS as novel sites for GLP-1R-mediated control of food intake and body weight.

Citing Articles

An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking.

Merkel R, Hernandez N, Weir V, Zhang Y, Caffrey A, Rich M Sci Adv. 2025; 11(9):eadr5051.

PMID: 40009667 PMC: 11864183. DOI: 10.1126/sciadv.adr5051.

Use of semaglutide in a 54-year-old patient with cocaine abuse and weight loss: a case report.

Romeo V J Med Case Rep. 2025; 19(1):57.

PMID: 39962582 PMC: 11834608. DOI: 10.1186/s13256-025-05049-w.

Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder.

Klausen M, Knudsen G, Vilsboll T, Fink-Jensen A Basic Clin Pharmacol Toxicol. 2025; 136(3):e70004.

PMID: 39891507 PMC: 11786240. DOI: 10.1111/bcpt.70004.

Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala.

Duran M, Willis J, Dalvi N, Fokakis Z, Virkus S, Hardaway J Endocrinology. 2025; 166(3).

PMID: 39888375 PMC: 11850305. DOI: 10.1210/endocr/bqaf019.

Glucagon-Like Peptide-1 Links Ingestion, Homeostasis, and the Heart.

Krieger J, Daniels D, Lee S, Mastitskaya S, Langhans W Compr Physiol. 2025; 15(1):e7.

PMID: 39887844 PMC: 11790259. DOI: 10.1002/cph4.7.

References

Ruttimann E, Arnold M, Hillebrand J, Geary N, Langhans W . Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology. 2008; 150(3):1174-81. PMC: 2654737. DOI: 10.1210/en.2008-1221. View

Drewnowski A . Obesity and the food environment: dietary energy density and diet costs. Am J Prev Med. 2004; 27(3 Suppl):154-62. DOI: 10.1016/j.amepre.2004.06.011. View

Raun K, von Voss P, Knudsen L . Liraglutide, a once-daily human glucagon-like peptide-1 analog, minimizes food intake in severely obese minipigs. Obesity (Silver Spring). 2007; 15(7):1710-6. DOI: 10.1038/oby.2007.204. View

Fulton S, Pissios P, Manchon R, Stiles L, Frank L, Pothos E . Leptin regulation of the mesoaccumbens dopamine pathway. Neuron. 2006; 51(6):811-22. DOI: 10.1016/j.neuron.2006.09.006. View

Holst J . The physiology of glucagon-like peptide 1. Physiol Rev. 2007; 87(4):1409-39. DOI: 10.1152/physrev.00034.2006. View

Larsen P, Tang-Christensen M, Holst J, Orskov C . Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience. 1997; 77(1):257-70. DOI: 10.1016/s0306-4522(96)00434-4. View

Dickson S, Egecioglu E, Landgren S, Skibicka K, Engel J, Jerlhag E . The role of the central ghrelin system in reward from food and chemical drugs. Mol Cell Endocrinol. 2011; 340(1):80-7. DOI: 10.1016/j.mce.2011.02.017. View

Hayes M, De Jonghe B, Kanoski S . Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol Behav. 2010; 100(5):503-10. PMC: 2886183. DOI: 10.1016/j.physbeh.2010.02.029. View

Buse J, Henry R, Han J, Kim D, Fineman M, Baron A . Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care. 2004; 27(11):2628-35. DOI: 10.2337/diacare.27.11.2628. View

10.

Khaimova E, Kandov Y, Israel Y, Cataldo G, Hadjimarkou M, Bodnar R . Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats. Brain Res. 2004; 1026(2):284-94. DOI: 10.1016/j.brainres.2004.08.032. View

11.

Carlezon Jr W, Thomas M . Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology. 2008; 56 Suppl 1:122-32. PMC: 2635333. DOI: 10.1016/j.neuropharm.2008.06.075. View

12.

Hayes M, Kanoski S, Alhadeff A, Grill H . Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats. Obesity (Silver Spring). 2011; 19(7):1342-9. DOI: 10.1038/oby.2011.50. View

13.

Abizaid A . Ghrelin and dopamine: new insights on the peripheral regulation of appetite. J Neuroendocrinol. 2009; 21(9):787-93. DOI: 10.1111/j.1365-2826.2009.01896.x. View

14.

Babcock A, Livosky M, Avery D . Cholecystokinin and bombesin suppress operant responding for food reward. Pharmacol Biochem Behav. 1985; 22(5):893-5. DOI: 10.1016/0091-3057(85)90543-x. View

15.

Hayes M, Leichner T, Zhao S, Lee G, Chowansky A, Zimmer D . Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab. 2011; 13(3):320-30. PMC: 3108145. DOI: 10.1016/j.cmet.2011.02.001. View

16.

Kinzig K, DAlessio D, Seeley R . The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci. 2002; 22(23):10470-6. PMC: 6758755. View

17.

Vrang N, Hansen M, Just Larsen P, Tang-Christensen M . Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei. Brain Res. 2007; 1149:118-26. DOI: 10.1016/j.brainres.2007.02.043. View

18.

Hayes M, Bradley L, Grill H . Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology. 2009; 150(6):2654-9. PMC: 2689794. DOI: 10.1210/en.2008-1479. View

19.

Drewnowski A, Rolls B . How to modify the food environment. J Nutr. 2005; 135(4):898-9. DOI: 10.1093/jn/135.4.898. View

20.

Norgren R, Hajnal A, Mungarndee S . Gustatory reward and the nucleus accumbens. Physiol Behav. 2006; 89(4):531-5. PMC: 3114426. DOI: 10.1016/j.physbeh.2006.05.024. View